We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Versant Corp. (MM) | NASDAQ:VSNT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.95 | 0 | 00:00:00 |
NEW YORK, Oct. 23, 2012 /PRNewswire/ --
Cascade Corporation
Levi & Korsinsky is investigating the Board of Directors of Cascade Corporation (NYSE: CASC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Toyota Industries Corporation for $65 per share. Shareholders representing a combined 14% of Cascade's outstanding shares have already agreed to tender their shares.
Click here to learn more about the investigation: http://zlk.9nl.com/cascade-corporation-casc or call: 877-363-5972.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
Cymer Inc.
Levi & Korsinsky is investigating the Board of Directors of Cymer Inc. (NasdaqGS: CYMI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to ASML Holding for cash and stock totalling approximately $79 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/cymer-cymi or call: 877-363-5972.
Versant Corp.
Levi & Korsinsky is investigating the Board of Directors of Versant Corp. (NASDAQ: VSNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to UNICOM Systems, Inc. for $11.50 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/versant-vsnt or call: 877-363-5972.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.
For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm. You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
Copyright 2012 PR Newswire
1 Year Versant Chart |
1 Month Versant Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions